Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation

Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation

Abstract Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the treatment is no longer merely to reduce mortality...

Full description

Bibliographic Details
Main Authors: Yusuke Kaida, Takatoshi Kambe, Shintaro Kishimoto, Yusuke Koteda, Kenji Suda, Ryo Yamamoto, Tetsurou Imai, Takuma Hazama, Yoshimi Takamiya, Ryo Shibata, Hidemi Nishida, Seiya Okuda, Kei Fukami
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Renal Replacement Therapy
Subjects:
Kawasaki disease
Plasma exchange
Coronary artery
Online Access:http://link.springer.com/article/10.1186/s41100-017-0130-y

Internet

http://link.springer.com/article/10.1186/s41100-017-0130-y

Similar Items